课题基金 / 基金详情

Developing Proteolysis Targeted Chimeras (PROTACs) toindividual class-I Histone Deacetylase complexes

Developing Proteolysis Targeted Chimeras (PROTACs) toindividual class-I Histone Deacetylase complexes
开发针对单个 I 类组蛋白脱乙酰酶复合物的蛋白水解靶向嵌合体 (PROTAC)
批准号:
2264941
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Histone deacetylase (HDAC) enzymes regulate chromatin accessibility globally by maintaining the level and location of histone-acetylation across the genome. All processes that require access to DNA - transcription, DNA replication, DNA repair and chromosome segregation - are thus influenced by HDAC activity. The class-I HDACs (1, 2 and 3) perform this role as part of distinct multi-protein complexes (Sin3A, NuRD, CoREST, MiDAC and NCoR) which help direct their activity to specific loci and determine substrate specificity. Our long-term goal is to develop small-molecule inhibitors against each of these five complexes using a PROTAC approach. Proteolysis Targeting Chimaeras (PROTAC) are hetero-bifunctional molecules which incorporate a known binding moiety to the protein of interest (POI, e.g. an inhibitor), coupled to a ligand for an E3 ubiquitin ligase complex. Direct recruitment of the E3 ligase to the POI via the PROTAC, targets it for ubiquitination and ultimately degradation, thus down-regulating its activity. The aim of this studentship is to develop novel PROTAC-based tools to interrogate the roles of individual class-I HDAC complexes in cells at a fundamental level and identify lead compounds for the development of a new class of HDAC inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金